Peanut Oral Immunotherapy Study of Early Intervention for Desensitization
Public ClinicalTrials.gov record NCT03736447. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy and safety of AR101 in peanut-allergic children aged 1 to \< 4 years.
Study identification
- NCT ID
- NCT03736447
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 146 participants
Conditions and interventions
Conditions
Interventions
- AR101 powder provided in capsules & sachets Biological
- Placebo powder provided in capsules & sachets Biological
Biological
Eligibility (public fields only)
- Age range
- 1 Year to 3 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 26, 2018
- Primary completion
- Jul 4, 2022
- Completion
- Jul 4, 2022
- Last update posted
- Mar 1, 2023
2018 – 2022
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| Sean N. Parker Center for Allergy & Asthma Reseach, LPCH at El Camino Hospital | Mountain View | California | 94040 | — |
| Peninsula Research Associates, Inc. | Rolling Hills Estates | California | 90274 | — |
| Allergy & Asthma Medical Group and Research Center | San Diego | California | 92123 | — |
| Children's Center for Advanced Pediatrics Clinical Research Lab | Atlanta | Georgia | 30329 | — |
| Atlanta Allergy & Asthma Clinic | Marietta | Georgia | 30060 | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| The John Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| University of Michigan Division of Allergy and Clinical Immunology | Ann Arbor | Michigan | 48106 | — |
| Atlantic Research Center | Ocean City | New Jersey | 07712 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| UNC-CH School of Medicine, Pediatric Allergy, Immunology & Rheumatology, Food Allergy | Chapel Hill | North Carolina | 27599 | — |
| Clinical Research of Charlotte | Charlotte | North Carolina | 28277 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03736447, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03736447 live on ClinicalTrials.gov.